Unilamellar vesicles as potential capreomycin sulfate carriers: Preparation and physicochemical characterization
- 164 Downloads
The aim of this work was to evaluate unilamellar liposomes as new potential capreomycin sulfate (CS) delivery systems for future pulmonary targeting by aerosol administration. Dipalmitoylphosphatidylcholine, hydrogenated phosphatidylcholine, and distearoylphosphatidylcholine were used for liposome preparation. Peptide-membrane interaction was investigated by differential scanning calorimetry (DSC) and attenuated total internal reflection Fourier-transform infrared spectroscopy (ATIR-FTIR). Peptide entrapment, size, and morphology were evaluated by UV spectrophotometry, photocorrelation spectroscopy, and transmission electron microscopy, respectively. Interaction between CS and the outer region of the bilayer was revealed by DSC and ATIR-FTIR. DSPC liposomes showed enhanced interdigitation when the CS molar fraction was increased. Formation of a second phase on the bilayer surface was observed. From kinetic and permeability studies, CS loaded DSPC liposomes resulted more stable if compared to DPPC and HPC over the period of time investigated. The amount of entrapped peptide oscillated between 10% and 13%. Vesicles showed a narrow size distribution, from 138 to 166 nm, and a good morphology. These systems, in particular DSPC liposomes, could represent promising carriers for this peptide.
Keywordscapreomycin sulfate liposomes DSC ATIR-FTIR phase transition
Unable to display preview. Download preview PDF.
- 1.Maher D, Floyd K, Raviglione M. A strategic framework to decrease the burden of TB/HIV. WHO report, World Health Organization/ Communicable Disease/Tuberculosis, 2002; 296.Google Scholar
- 2.Vigorita MG, Ottana R, Zappalà C, Maccari R, Pizzimenti FC, Gabrielli G. Halogenated isoniazid derivatives as possible antimy cobacterial and anti-HIV agents-III.IL Farmaco. 1994;49:775–781.Google Scholar
- 4.Gursoy A. Liposome-encapsulated antibiotics: Physicochemical and antibacterial properties, a review.STP Pharma Sci. 2000;10(4):285–291.Google Scholar
- 5.Deol P, Khuller GK. Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice.Biochim Biophys Acta 1997;1334:161–172.Google Scholar
- 7.Le Conte P, Le Gallou F, Potel G, Struillou L, Baron D, Drugeon HB. Pharmacokinetics, toxicity, and efficacy of liposomal capreomycin in disseminatedMycobacterium avium beige mouse model.Antimicrob Agents Chemother. 1994;38:2695–2701.Google Scholar
- 8.Martindale the Extra Pharmacopoeia. Capreomycin sulfate (7554-1).The Complete Drug Reference—Monographs. 3 2nd ed. Parfitt K editor, The Pharmaceutical Press, London, UK; 1997:162.Google Scholar
- 21.Goormaghtigh E, Raussens V, Ruysschaert JM. Attenuated total reflection infrared spectroscopy of proteins and lipids in biological membranes.Biochim Biophys Acta 1999;1422:105–185.Google Scholar
- 22.Jain MK. Order and dynamics in bilayers and solute in bilayers. In: Jain MK, ed.Introduction to Biological Membranes. New York, NY: Wiley, 1988:122–165.Google Scholar
- 24.Weers JG, Scheuing DR. Characterization of viscoelatic surfactant mixtures, I: Fourier transform infrared spectroscopic studies.Colloids Surf. B: Biointerfaces, 1991;55:41–56.Google Scholar
- 25.Fringeli UP, Guenthard HH. Infrared membrane spectroscopy.Mol Biol Biochem Biophys. 1981;31:270–332.Google Scholar
- 26.Guenzler H, Boeck H.IR Spectroscopy. An Introduction. 2nd ed. Weinheim, Germany: Verlag Chemie, 1983:403. (In German).Google Scholar